|

|
Our contributions
|
| |
|
| - |
Cost
optimization |
| - |
High accurate
optics |
| - |
Mechatronics |
| - |
Fast image acquisition and processing |
|
Untreated eye defects leading to permanently
impaired vision and even blindness are a serious
problem in the developing world. It's a sad fact
that 90% of the world's blind people, amounting to
45 million people, live in developing countries. And
many of the conditions causing their blindness, such
as glaucoma, diabetic retinopathy and childhood
blindness could easily have been treated if detected
early enough through screening. Recognizing the
scale of this problem, Philips consulted with
leading ophthalmologists within India who showed
great interest in the development of a simple
eye-screening device that could be used by
paramedics or people without formal medical
training.
Automatic analyzing and diagnostics of the eyes
Essentially the device should be handheld or head
mounted, be relatively inexpensive, operate in areas
without a regular power grid and embody an 'expert
system' capable of automatically analyzing the
measurements and giving advice about whether the
patient should see a doctor or specialist for
treatment, or have medication prescribed in an early
phase, when the disease still can be treated. The
device embodies three essential functions: a retinal
camera, an autorefractor for measuring refractive
errors and a tonometer for eye pressure measurement.
In contrast to specialist clinical systems, it
should also not require calibration.
Translating consumer system insight into
ophthalmic healthcare
To
address the low-cost requirement, Philips Applied
Technologies is drawing on its expertise in consumer
systems and is currently developing a prototype
retinal camera using a commercially available webcam
plus specially developed optics. Although
development of the autorefractor has not yet
started, feasibility studies indicate that a
successful design could use many of the same optical
elements as the retinal camera combined with LEDs
and photocells to stimulate and measure corneal
reflex. It's anticipated that the biggest challenge
will be integrating the tonometer into the device.
Elevated eye pressure is one of the early
indications of glaucoma and the tonometer determines
this by measuring the deformation of the eye caused
by a brief puff of air. To help meet this challenge,
we will utilize the expertise of our mechatronics
group. The image processing and interpretation
software will be developed in parallel with the
hardware, drawing on the company's know-how in
imaging software for clinical systems.
The
aim is for screening to cost no more than around 60
Euro cents per examination which may be government
supported or subsidized by hospitals that will see
the screening programs as a means of increasing
their patient catchment population. Pharmaceutical
companies too, may also be prepared to support
screening programs which will inevitably lead to an
earlier usage of eye drops or other drugs.
The innovative eye-screening device has already
stimulated considerable interest among leading eye
hospitals within the developing countries.
|